Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment

The impact of preexisting antibodies to the four endemic human coronaviruses (ehCoV) (229E, OC43, NL63, and HKU1) on severe (hospitalization) coronavirus disease 2019 (COVID-19) outcomes has been described in small cohorts. Many studies have measured ehCoV 229E, OC43, NL63, and HKU1 antibody levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaba, Andrew H., Johnston, Trevor S., Beck, Evan, Laeyendecker, Oliver, Cox, Andrea L., Klein, Sabra L., Sullivan, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973272/
https://www.ncbi.nlm.nih.gov/pubmed/36625657
http://dx.doi.org/10.1128/mbio.03287-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973272/
https://www.ncbi.nlm.nih.gov/pubmed/36625657
http://dx.doi.org/10.1128/mbio.03287-22

Ejemplares similares